Identification of undiagnosed inflammatory arthritis in a community health fair screen
- PMID: 19950306
- PMCID: PMC2913880
- DOI: 10.1002/art.24834
Identification of undiagnosed inflammatory arthritis in a community health fair screen
Abstract
Objective: To identify individuals with undiagnosed inflammatory arthritis (IA) and rheumatoid arthritis (RA) in a community health fair screen, and to establish in a health fair setting the diagnostic accuracy of combinations of the Connective Tissue Disease Screening Questionnaire (CSQ) and autoantibody testing for IA.
Methods: Screening for IA/RA was performed at health fair sites using a combination of the CSQ, joint examination, rheumatoid factor, and anti-cyclic citrullinated peptide (anti-CCP) antibody testing. IA was defined as > or =1 swollen joint suggestive of synovitis on joint examination by a trained clinician.
Results: Six hundred one subjects were screened; 51.0% participated because of joint symptoms (pain, stiffness, or swelling). Eighty-four subjects (14.0%) had > or =1 swollen joint, designated as IA on joint examination. Of the 601 subjects screened, 9 (1.5%) had IA and met > or =4 of 7 American College of Rheumatology criteria for RA but had no prior diagnosis of RA, and 15 (2.5%) had IA and RF and/or anti-CCP positivity, suggesting early RA. The diagnostic accuracy of combinations of the CSQ and autoantibody testing for the identification of IA yielded maximal sensitivity, specificity, and positive and negative predictive values of 95.3%, 99.2%, 71.4%, and 97.7%, respectively.
Conclusion: Health fair screening may be an effective approach for the identification of individuals with undiagnosed IA/RA. A combination of the CSQ and autoantibody testing alone has clinically useful diagnostic accuracy for the detection of IA. Decisions regarding which methodology to use for future health fair IA/RA screening will depend on goals of screening and funding.
References
-
- Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008 Jan;58(1):15–25. - PubMed
-
- Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008 Sep–Oct;26(5 Suppl 5):S35–61. - PubMed
-
- Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum. 2008 Feb;58(2 Suppl):S126–35. - PubMed
-
- Cush JJ. Early rheumatoid arthritis -- is there a window of opportunity? J Rheumatol Suppl. 2007 Nov;80:1–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K23 AR051461/AR/NIAMS NIH HHS/United States
- T32-AR007534-23/AR/NIAMS NIH HHS/United States
- K24-AR0524-01/AR/NIAMS NIH HHS/United States
- P60 AR047782/AR/NIAMS NIH HHS/United States
- K24 AR052403/AR/NIAMS NIH HHS/United States
- L30 AR050481/AR/NIAMS NIH HHS/United States
- R01-AR051394/AR/NIAMS NIH HHS/United States
- K23-AR051461/AR/NIAMS NIH HHS/United States
- T32 AR007534/AR/NIAMS NIH HHS/United States
- R01-AR49880/AR/NIAMS NIH HHS/United States
- P60-AR047782/AR/NIAMS NIH HHS/United States
- R01 AR051394/AR/NIAMS NIH HHS/United States
- R01 AR049880/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
